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Abstract
Background: The HIV-1 regulatory protein Rev, which is essential for viral replication, mediates the nuclear export
of unspliced viral transcripts. Rev nuclear function requires active nucleocytoplasmic shuttling, and Rev nuclear
import is mediated by the recognition of its Nuclear Localisation Signal (NLS) by multiple import factors, which
include transportin and importin b. However, it remains unclear which nuclear import pathway(s) predominate in
vivo, and the cellular environment that modulates Rev nucleocytoplasmic shuttling remains to be characterised.
Results: In our study, we have identified the cellular protein HIC (Human I-mfa domain-Containing protein) as a
novel interactor of HIV-1 Rev. We demonstrate that HIC selectively interferes with Rev NLS interaction with importin
b and impedes its nuclear import and function, but does not affect Rev nuclear import mediated by transportin.
Hence, the molecular determinants mediating Rev-NLS recognition by importin b and transportin appear to be
distinct. Furthermore, we have employed HIC and M9 M, a peptide specifically designed to inhibit the transportin-
mediated nuclear import pathway, to characterise Rev nuclear import pathways within different cellular
environments. Remarkably, we could show that in 293T, HeLa, COS7, Jurkat, U937, THP-1 and CEM cells, Rev nuclear
import is cell type specific and alternatively mediated by transportin or importin b, in a mutually exclusive fashion.
Conclusions: Rev cytoplasmic sequestration by HIC may represent a novel mechanism for the control of Rev
function. These studies highlight that the multivalent nature of the Rev NLS for different import receptors enables
Rev to adapt its nuclear trafficking strategy.
Background
The HIV-1 regulatory protein Rev (18 kDa) is essential
for HIV-1 replication [1,2]. Rev is predominantly loca-
lised in the nucleus/nucleolus [3], and its primary func-
tion is to mediate the nuclear export of partially spliced
and unspliced viral transcripts. Rev has also been shown
to modulate splicing and translation of viral transcripts,
and their subsequent packaging, and to interfere with
integration of the HIV-1 genome [4-7]. Rev nuclear
export of unspliced viral transcripts requires active shut-
tling of the protein between the nucleus and cytoplasm
via nuclear pore complexes (NPCs) which is mediated by
two major functional domains, the Nuclear Localisation
Signal (NLS) and the Nuclear Export Signal (NES) [8,9].
The leucine-rich Rev NES binds directly to CRM1, which
in concert with DDX3, a DEAD box RNA helicase, facili-
tates Rev nuclear export of unspliced viral transcripts via
the NPC [10-14]. Also, Rev-export function was shown
to be inhibited by Nuclear Factor 90 (NF90)[15]. The
basic arginine-rich Rev NLS mediates both Rev nuclear
import and binding to the Rev Response Element (RRE),
a cis-acting RNA element present in all unspliced viral
transcripts [16-18]. The Rev NLS is recognized by at least
5 different importin b family members, including impor-
tin b, transportin, importin 5, importin 7 and importin 9,
which facilitate its nuclear import [19-23]. Despite evi-
dence showing the utilisation of multiple nuclear import
receptors in vitro by Rev, it remains unclear if some are
redundant and/or if, under specific conditions, one
nuclear import pathway may predominate in vivo. Hutten
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any medium, provided the original work is properly cited.et al. described transportin as a major Rev nuclear import
receptor [23]. However, this study was restricted to HeLa
cells, and the molecular and cellular determinants gov-
erning the interaction of Rev with one or the other
nuclear import receptors have not been investigated.
In this report, we identified a novel interaction
between HIV-1 Rev and the cellular protein HIC
(Human I-mfa domain-Containing protein). HIC is a
246 amino acid protein with a prominently cytoplasmic
distribution. The cysteine-rich C-terminal domains of
HIC and the Inhibitor of MyoD family a (I-mfa) share a
high homology (74%) and are essential for their activities
[24]. HIC acts as a regulator of transcription and inter-
acts with and/or modulates the activity of several cellu-
lar and viral transcription factors, including Axin, cyclin
T1 and T2, TCF1, HIV-1 Tat, HTLV-1 Tax and KSHV
LANA [24-29]. We previously reported that the ectopic
expression of HIC resulted in the mislocalisation of
HIV-1 Tat to the cytoplasm. This contrasted with an
earlier report which showed that Tat and HIC co-loca-
lised in the nucleolus [28]. Nevertheless, these studies
were descriptive, and the effects of HIC on the nuclear
transport machinery were not investigated.
In this report, we explored the mechanisms whereby
HIC could regulate Rev nuclear import and demon-
strated that HIC selectively blocks importin b-b u tn o t
transportin-mediated Rev nuclear import via a mechan-
ism involving the intermolecular masking of Rev NLS by
HIC. In addition, we employed HIC, as an inhibitor of
importin b mediated Rev nuclear import, and M9 M, a
peptide which specifically inhibits the transportin path-
way, as tools to further characterise Rev nuclear import
pathway(s) in HeLa, 293T, COS7, Jurkat, CEM, THP-1
and U937 cells. While we confi r m e dt h a tt r a n s p o r t i ni s
the major import receptor for Rev in HeLa, THP-1 and
U937 cells, we showed that in 293T, COS7, CEM and
Jurkat cells, importin b-mediated Rev nuclear import is
dominant. Subsequently, reporter gene assays revealed
that HIC contributes to the control of Rev function in
293T Jurkat and CEM but not in HeLa, U937 and THP-
1 cells. Collectively these results demonstrate that Rev
nuclear import is tightly regulated and suggest that the
molecular determinants mediating Rev transport by
importin b and transportin are distinct, and that the Rev
dominant nuclear import pathway is cell type specific.
Results
HIC sequesters Rev in the cytoplasm by inhibiting its
nuclear import in vivo
We performed colocalisation studies in COS7 cells
transfected with HIC, its mutants and Rev. The localiza-
tion of HIC and the mutant, HIC (2-144) was primarily
cytoplasmic, although they could be detected in the
nucleus (Figure 1A). Interestingly, HIC (144-246) was
localized widely in the cytoplasm and nucleus in a dif-
fuse manner (Figure 1A). The majority of cells expres-
sing Rev did so exclusively in the nucleus and/or
nucleolus (68%), while in the remainder, Rev was pre-
sent in the cytoplasm only, or diffusely in the cytoplasm
and nucleus (Figure 1A, B, and 1C, upper column). In
contrast, when Rev was co-expressed with HIC or HIC
(144-246) containing the I-mfa domain, both colocalised
in the cytoplasm and the percentage of cells displaying
Rev in the nucleus was significantly reduced (19% and
22% for HIC and HIC (144-246), respectively) (Figure
1 A ,B ,a n d1 C ,u p p e rp a n e l ) .I n t e r e s t i n g l y ,H I C( 2 - 1 4 4 )
did not co-localise with Rev, or influence its nuclear
localisation (57%) (Figure 1A, B, and 1C, upper panel).
To further evaluate if the cytoplasmic redistribution of
Rev by HIC is associated with a reduction in Rev
nuclear accumulation, we quantified Rev nuclear signal
intensity with the ImageJ 1.41 software (NIH) on 100
cells expressing Rev in the presence or absence of HIC
and its mutants. We could observe a significant reduc-
tion (48%) in Rev nuclear signal intensity when Rev was
co-expressed with HIC or HIC (144-246), while HIC (2-
144) did not influence Rev nuclear signal intensity (Fig-
ure 1D, lower panel). Therefore, the ectopic expression
of HIC results in the cytoplasmic redistribution of Rev
with a concomitant reduction in its nuclear accumula-
tion and this effect was dependent on the I-mfa domain.
To determine whether HIC inhibits Rev nuclear
import or promotes Rev nuclear export, we repeated the
colocalisation studies, in the presence of Leptomycin B,
which specifically inhibits nuclear export mediated by
CRM1 [11]. Since Rev localisation is the result of a net
balance between Rev import and export, treatment with
LMB interrupted the nuclear export and resulted in an
overall increase in Rev nuclear localisation, as deter-
mined by an increase in both the number of cells dis-
playing Rev exclusively in the nucleus and Rev nuclear
signal intensity (Figure 1D). However, LMB did not pre-
vent the overall effects of HIC on Rev cytoplasmic redis-
tribution. Indeed when Rev was co-expressed with HIC,
the percentage of cells displaying Rev in the nucleus
decreased from 83% (Rev alone+LMB) to 43% (Rev+HIC
+LMB) (Figure 1D upper panel). In addition, the Rev
nuclear signal intensity also decreased from 72% (Rev
alone+LMB) to 40% (Rev+HIC+LMB) (Figure 1D, lower
panel). These observations support the view that HIC
most likely sequesters Rev in the cytoplasm by inhibiting
its nuclear import rather than promoting its nuclear
export.
HIV-1 Rev nuclear import mediated by importin b is
selectively blocked in vitro by a competitive excess of HIC
To examine the mechanisms regulating Rev nuclear
import, we performed in vitro nuclear import assays,
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Page 2 of 13Figure 1 HIC sequesters HIV-1 Rev in the cytoplasm by inhibiting its nuclear import in vivo. COS7 cells were transiently transfected with
HA-Rev; pFLAG-HIC; pFLAG-HIC (2-144); pFLAG-HIC (144-246). Rev expression is shown in Red and HIC, HIC (2-144) and HIC (144-246) expression
is shown in Green. Nuclei were counterstained with DAPI (Blue). Representative images of transfected cells are shown. Arrows indicate cells
expressing Rev only. (A) Localisation of Rev, HIC and its mutants in singly transfected COS7 cells. (B) Co-expression of HIV-1 Rev and
HIC or HIC (144-246) results in the redistribution of Rev to the cytoplasm. (C) Quantitative analysis of Rev nuclear localization. Same
conditions as described in B. Upper panel: quantitative analysis of Rev subcellular localisation. A minimum of 100 transfected cells was counted
per well and results are expressed as a percentage of the total number of cells counted according to the classification: nucleus-dominant (blue),
nucleus/cytoplasm-equivalent (yellow), or cytoplasm-dominant (red). Lower panel: quantitative analysis of Rev nuclear signal. Rev nuclear signal
intensities were analyzed by Image J (NIH) from a minimum of 100 transfected cells and shown by box plots. Statistical significance analysis was
performed with a two-tailed unpaired Student’s t test *, P < 0.05; **, P < 0.01. (D) HIC retains Rev in the cytoplasm by inhibiting its nuclear
import. COS7 cells were transfected with HA-Rev, and/or pFLAG-HIC and incubated with or without 20 nM Leptomycin B (LMB) for 3 hours.
Upper panel: quantitative analysis of Rev subcellular localisation. Lower panel: quantitative analysis of Rev nuclear signal.
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protein HIC was employed. HeLa cells were treated with
digitonin, which selectively permeabilises the cytoplas-
mic membrane and rabbit reticulocyte lysate (RRL) was
employed as a source of import factors with recombi-
nant GST-YFP-Rev, GST-YFP-M9 or GST SV40TNLS-
GFP being used as fluorescent import substrates. M9,
which is imported into the nucleus by transportin, inde-
pendently of the importin a/b pathway, and SV40T
NLS, which is imported to the nucleus by the importin
a/b pathway, were employed as controls [30,31]. We
first confirmed that the nuclear import of the substrates
was actively and selectively mediated by cellular factors
through the NPC, in an energy and RanGTP-dependent
manner (data not shown). Subsequently, addition of
competitive and increasing amounts of HIC recombi-
nant protein (0.5-2 μg) resulted in a decreased signal
intensity in the nucleus for Rev and for SV40T NLS, in
a dose dependent manner (Figure 2A). In contrast, HIC
did not affect M9 nuclear import (Figure 2A), demon-
strating that Rev and SV40T NLS nuclear import is
selectively and efficiently inhibited by HIC and is not
the result of a general block of nuclear import pathways
or obstruction of the NPC.
To further dissect the mechanisms underlying HIC
inhibition of Rev nuclear import, we reduced the com-
plexity of this system, by employing 2 μg of recombinant
importin b or transportin, as sole import factors.
Remarkably, HIC efficiently and distinctively abolished
Rev nuclear import mediated by importin b but not by
transportin (Figure 2B). As previously shown, HIC did
not block transportin mediated nuclear import of M9.
To further examine the effect of HIC on importin b-
mediated Rev import, we performed similar experiments
with Rev mutants (GST-YFP-RevΔN1/-RevΔN2/-
RevNLS) with or without deletions of the Rev NLS
domain (Figure 2C). Strong fluorescent signals were
observed in the nucleus for both RevΔN1 and RevNLS,
both of which encompass the functional NLS sequence,
while RevΔN2 lost its nuclear localisation due to the
absence of the NLS domain (Figure 2C). The addition of
increasing amounts of HIC (0.5-2 μg) correlated with a
decreasing nuclear signal intensity for both RevΔN1 and
RevNLS (Figure 2C), demonstrating that the RevNLS is
sufficient and necessary for both Rev nuclear import
and its inhibition by HIC.
HIV-1 Rev and HIC interact directly in vitro and form a
complex in vivo
We examined whether HIC-mediated inhibition of Rev
nuclear import involves a direct interaction by perform-
ing in vitro GST-pull downs with recombinant HIC and
GST-YFP (control), or GST-YFP fusion proteins (GST-
YFP-Rev/-RevΔN1/-RevΔN2/-RevNLS). HIC was
specifically detected in the eluted fractions of GST-YFP
Rev/-RevΔN1/-RevNLS, all of which contained the NLS
domain, whereas there was no association between HIC
and GST-YFP or GST-YFP-RevΔN2, which lack the
NLS domain (Figure 3A). These results demonstrate
that HIC physically interacts with Rev and that the Rev
NLS is sufficient and necessary to mediate this interac-
tion. Similarly, we conducted in vitro GST-pull down
assays, which demonstrated that SV40T NLS, but not
importin a,i m p o r t i nb or M9 directly interacts with
HIC (Figure 3A) and this again excluded the possibility
that HIC mediates a general nuclear import block by
physically targeting the import factors.
Subsequently, co-immunoprecipitation assays were
employed to investigate potential interactions between
HIV-1 Rev and HIC in transfected 293T cells. HA-Rev
was immunoprecipitated and HIC was specifically
detected in the eluted fraction (Figure 3B). Similarly, the
HIC mutant (144-246), which contains the I-mfa
domain, but not the HIC mutant (2-144), interacted
with Rev (Figure 3B). Thus, HIC and Rev interact in
vivo and in vitro, and this interaction is mediated by the
I-mfa domain of HIC and Rev NLS domain.
HIC selectively interferes with the Rev NLS interaction
with importin b
We next assessed whether competition between HIC
and importin b for Rev binding might account for the
observed reduced nuclear import and performed in vitro
binding assay in which HIC with either importin b or
transportin compete for GST-YFP-Rev binding (Figure
4A, B). HIC selectively interfered with the binding of
Rev to importin b but not transportin in a dose depen-
dent manner. Indeed, maximum amounts of HIC
recombinant protein were sufficient to fully abolish the
binding of importin b to Rev. Remarkably, similar
results were obtained when using Rev-NLS (Figure 4C,
D). Of note, Rev could bind simultaneously to both HIC
and transportin.
The dominant Rev nuclear import pathway is cell type
dependent
Hutten et al. have reported that transportin, but not
importin b, could mediate Rev nuclear import in HeLa
cells [23]. Here, we use selective inhibition of importin
b-mediated Rev nuclear import by HIC and the M9 M
peptide, the latter which specifically inhibits the trans-
portin pathway to further characterise Rev dominant
nuclear import pathway(s) [32] (Figure 5). We employed
HeLa, 293T, COS7, U937 (monocytic leukemia), Jurkat
(E6-1 clone; T lymphocyte), THP-1 (Acute monocytic
leukemia) and CEM (T cell leukemia) cell cytosolic
extracts as seven distinct sources of import receptors in
our in vitro nuclear import assays (Figure 6 and Figure
Gu et al. Retrovirology 2011, 8:17
http://www.retrovirology.com/content/8/1/17
Page 4 of 13Figure 2 HIV-1 Rev nuclear import mediated by importin b is selectively blocked in vitro by competitive excess of HIC. Nuclear import
of GST-YFP-Rev, GST-SV40TNLS-GFP and GST-YFP-M9 was examined using in vitro nuclear import assays. Digitonin permeabilised HeLa cells were
incubated with 10 μl of reaction mixtures containing 1 μg of import substrate, ATP regeneration system and nuclear import factors.
Recombinant 6×His-HIC (0.5, 1 or 2 μg) was added to investigate the effect on Rev nuclear import. In all the cases, Rev nuclear signal intensities
were analyzed by ImageJ for a minimum of 100 cells and illustrated by box plots (arbitrary units). Statistical significance analysis was performed
with a two-tailed unpaired Student’s t test *, P < 0.05; **, P < 0.01; ***, P < 0.001 (A) Recombinant HIC protein abolishes Rev nuclear import.
Rabbit Reticulocyte Lysate (RRL) was employed as source of multiple import factors. (B) HIC specifically inhibits Rev nuclear import mediated
by importin b but not by transportin.2μg of recombinant importin b or transportin was employed as the only source of import factor. (C)
Schematic representation of HIV-1 Rev and deletion mutants. (D) Rev NLS domain is necessary and sufficient for Rev nuclear import
inhibition by HIC. Nuclear imports of GST-YFP-Rev, GST-YFP-RevΔN1, GST-YFP-RevΔN2 and GST-YFP-RevNLS were examined using in vitro nuclear
import assays. Importin b was employed as the only source of nuclear import factor.
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Page 5 of 13S1; Additional File 1). First, we established that (i) both
the importin b and transportin pathways were functional
in the seven cell lines tested, as shown by the effective
nuclear import of SV40T NLS and M9, and that (ii) all
the cell types dysplayed relatively similar expression
levels for transportin and importin b as revealed by
Western Blot analysis of the different cytosolic fractions
(Figure 6, Figure S1; Additional File 1 and Figure S2;
Additional File 2). In parallel, endogenous HIC expres-
sion was observed in all the cell types except Jurkat cells
(Figure S2; Additional File 2). Next, we confirmed in all
the cell lines analysed, that HIC and M9 M could
efficiently and selectively block the importin and trans-
portin pathways respectively. Indeed, HIC inhibited
SV40T NLS, but not M9 nuclear import, while M9 M
inhibited M9, but not SV40T NLS nuclear import
(Figure 6 and Figure S1; Additional File 1).
Remarkably, HIC selectively blocked Rev nuclear
import in the presence of 293T, COS7, CEM or Jurkat
cytosolic extracts (Figure 6 and Figure S1; Additional File
1). However, its nuclear import remained unaffected by
HIC when HeLa, THP-1 or U937 cytosolic extracts were
employed (Figure 6 and Figure S1; Additional File 1). In
contrast, M9 M inhibited Rev nuclear import when
HeLa, THP-1 or U937 cytosolic extracts were employed
but did not affect Rev nuclear import mediated by 293T,
COS7, CEM or Jurkat cytosolic extracts (Figure 6 and
Figure S1; Additional File 1). These results are consistent
with Hutten et al. [23] and support their finding that
transportin is the major nuclear import receptor for Rev
in HeLa cells. Additionally, our results demonstrated that
transportin is also the primary import factor in U937 and
THP-1 cells. In 293T, COS7, CEM and Jurkat however,
the Rev dominant nuclear import pathway appears to
involve importin b, which is consistent with our co-loca-
lisation assay performed in COS7 cells.
Figure 3 HIV-1 Rev and HIC interact directly in vitro and form a
complex in vivo. (A) GST pull-down assays show that Rev NLS
(upper panel) and SV40T NLS (lower panel) interact directly
with HIC in vitro. Purified recombinant HIC protein was incubated
with immobilised GST-YFP (control) and various GST-YFP fusions
proteins (bait). Interacting proteins were subsequently eluted and
resolved by SDS-PAGE. HIC was detected by Western Blot analysis
and Commassie staining indicated the quantity and quality of GST
fusion proteins employed. (B) HIV-1 Rev and HIC form a complex
in vivo. 293T cells were transiently transfected with HA-Rev, pFLAG-
HIC/-HIC (2-144)/-HIC (144-246). Input and immunoprecipitates were
analysed by Western-Blot (WB) to examine expression levels of Rev,
HIC and its mutants, and co-immunoprecipitation of HIC, HIC (144-
246) and HA-Rev, respectively. Similar to previous studies and for
reasons that remain unclear HIC mutant (144-246) expression was
difficult to detect in the input [25,28].
Figure 4 HIC interferes with HIV-1 Rev molecular recognition
by importin b in vitro. Immobilised GST-YFP-Rev/-Rev NLS were
incubated with 6xHis-importin b or 6xHis-transportin and 0.5-4 μg
of 6xHis-HIC. Following GST pull-down assays, Commassie staining
shows that HIC specifically competes with the binding of Rev (A) or
Rev NLS (B) to importin b. HIC does not interfere with the binding
of Rev (C) or Rev NLS (D) to transportin.
Figure 5 Molecular Mechanisms of HIV-1 Rev nuclear import
inhibition by HIC and M9M. (A) Rev nuclear import mediated by
importin b. (B) HIC interferes with the interaction of Rev NLS with
importin b and as a results impedes Rev nuclear import. (C) M9 M
does not interfere with importin b-mediated Rev nuclear import. (D)
Rev nuclear import mediated by transportin. (E) Rev binds
simultaneously to both HIC and transportin, which mediate its
nuclear import. (F) M9 M tightly interacts with transportin and
inhibits transportin mediated Rev nuclear import.
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We next sought to examine the biological relevance of
HIC and Rev interaction on Rev activity employing the
CAT reporter gene pDM128-RRE (28). The vector
pDM128-RRE expresses transcripts consisting of a spli-
cing donor site and a splicing acceptor site flanking the
CAT gene and HIV-1 RRE cis-acting element. The
unspliced transcripts are only exported to the cytoplasm
in the presence of Rev, which ultimately results in the
expression of the CAT protein (28). First, 293T cells
were transfected with HA-Rev, FLAG-HIC and
pDM128-RRE and assayed for CAT expression levels by
ELISA. Rev induced a 17-fold increase in the CAT
expression in 293T cells. HIC did not affect the CAT
basal expression level (Figure 7A). In contrast, increas-
ing levels of HIC expression were correlated with
decreasing Rev activity in a dose-dependent manner. In
293T cells, maximal down-regulation of Rev activity cor-
responded to over 50% inhibition (Figure 7A). We then
repeated the Rev functional assays with HIC in HeLa
cells. Remarkably and in contrast to 293T cells, HIC
had a modest effect (12% reduction) on Rev function
(Figure 7B). Importantly, HIC overexpression did not
modulate Rev expression levels, as monitored by WB
analysis (Figure S3A; Additional File 3). We extended
this functional assay to additional cell lines. Similarly,
Figure 6 HIV-1 Rev dominant nuclear import pathways are cell specific. Nuclear import of GST-YFP-Rev, GST-YFP-M9 and GST-SV40T NLS-
GFP were examined using in vitro nuclear import assays. Digitonin permeabilized HeLa cells were incubated with 10 μl of reaction mixtures
containing 1 μg of an import substrate, ATP regeneration system, and 293T/HeLa/U937/Jurkat cytosolic extracts. Recombinant 6×His-HIC at 0.5, 1
or 2 μg was added. Rev nuclear signal intensities were analyzed by ImageJ for a minimum of 100 cells and illustrated by box plots. Statistical
significance analysis was performed with a two-tailed unpaired Student’s t test *, P < 0.05; **, P < 0.01; ***, P < 0.001
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cells while in U937 and THP-1 cells, Rev activity
remained unaffected by HIC overexpression (Figure 8).
These results strongly suggest that HIC inhibits Rev
activity in a cell-specific manner. Subsequently, to inves-
tigate the role of endogenous level of HIC expression on
Rev activity, we performed small interfering RNA
(siRNA)-mediated knockdown of HIC. As shown by
quantitative real-time RT-PCR, all three independent
HIC siRNAs, MDFIC_3, MDFIC_5 and MDFIC_7, effec-
tively down-regulated HIC mRNA expression (Figure
7C), in HeLa and 293T cells with MDFIC_3 being the
most effective siRNA (75% knockdown). These effects
were also observed at the protein levels (Figure S3B;
Additional File 3). In 293T, HIC knockdown resulted in
a marked increase, up to 240%, in Rev activity but did
not significantly affect Rev function in HeLa cells,
demonstrating that an endogenous level of HIC expres-
sion interferes with Rev function in a cell type specific
manner (Figure 7D). Importantly, HIC knock-down did
not affect Rev expression levels as determined by WB
analysis (Figure S3B; Additional File 3). Furthermore,
Figure 7 HIC inhibits HIV-1 Rev function in a cell-specific fashion. A. HIC down-regulates Rev activity in a dose dependent manner.
293T cells were transfected with 0.1 μg of pDM128-RRE combined with 0.05 μg of HA-Rev and 1, 2 or 4 μg of FLAG-HIC. Relative CAT activity is
compared with 100% for Rev activity of pDM128-RRE. Values are mean ± standard deviation. Data are representative of a minimum of three
independent experiments performed in duplicate. Statistical significance analysis was performed with a two-tailed unpaired Student’s t test *, P <
0.05; **, P < 0.01; ***, P < 0.001. B. The down-regulation of Rev activity by HIC is dependent on the I-mfa domain and is cell-specific.
293T or HeLa cells were transfected with 0.1 μg of pDM128-RRE combined with 0.05 μg of HA-Rev and 4 μg of FLAG HIC. Relative CAT activity
was analysed as described above. C. Evaluation of siRNA knockdown of HIC. Real-time RT-PCR analysis of HIC mRNA levels for HeLa and 293T
cells was performed at 72 hours following reverse transfection of three distinct HIC siRNAs or with siRNAs directed against luciferase (GL2) as
negative control. These experiments were each performed in duplicates and the mean average results are shown. D. Effects of siRNA
knockdown of HIC on Rev activity are cell-specific. 293T or HeLa cells were first reverse-transfected with three independent HIC siRNAs
(30pmoles) or negative control siRNA (30pmoles) and after 24 hours were transfected with 0.2 μg of pDM128-RRE, 0.02 μg RL-TK and 0.02 μgo f
HA-Rev or parent plasmid. Relative CAT activity was analysed as described above. Values are mean ± standard deviation. Data are representative
of a minimum of three independent experiments performed in duplicate.
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three independent siRNAs, strongly supports the view
that these effects were specific and cannot be attributed
to off-target silencing.
Collectively, these functional results correlate with HIC
selective inhibition of Rev nuclear import mediated by
293T, Jurkat or CEM cytosol or importin b,b u tn o tb y
HeLa, U937 or THP-1 cytosol and transportin and
strongly suggest that HIC contributes to the spatial con-
trol of Rev function in 293T, Jurkat and CEM cells.
Discussion
This study identifies the cellular protein HIC as a novel
interactor and regulator of HIV-1 Rev nuclear import
and function. First, using in vitro nuclear import assays,
we analysed the role of individual nuclear transport
machinery components in mediating Rev nuclear import
and employed importin b or transportin as the transport
receptors in the presence of a competitive amount of
recombinant HIC. We demonstrated that HIC selec-
tively inhibited Rev nuclear import mediated by impor-
tin b but not by transportin and that the Rev NLS
domain was sufficient and necessary for Rev nuclear
import inhibition by HIC. Additional controls and com-
plementary experiments demo n s t r a t e dt h a tH I Cs e l e c -
tively and physically targeted the Rev NLS domain and
not the import factors themselves. Furthermore, the
observed inhibition of Rev nuclear import did not result
from a general block of import pathways or the physical
obstruction of the NPC since M9 or Rev nuclear import
mediated by transportin remained unaffected by HIC.
The molecular recognition of NLSs by import receptors
in the cytoplasm determines their nuclear import rate
[33,34]. Based on the evidence herein, we propose that
the HIC I-mfa domain binds to Rev NLS and selectively
prevents its recognition by importin b and subsequent
nuclear import proteins. This is similar to I-B, which
interacts with and masks the NF-B NLS domain, also
preventing its nuclear import [35,36]. To extend our
study to an in vivo cellular context, we next demon-
strated that co-expression of HIC and Rev in COS7 cells
resulted in the cytoplasmic sequestration of Rev with a
concomitant reduction in its nuclear accumulation and
this was dependent on the HIC I-mfa domain. Then,
using leptomycin B, we further indicated that HIC most
likely inhibits Rev nuclear import rather than promoting
its nuclear export. This is also consistent with our com-
petitive nuclear import assay performed with COS7
cytosol.
I ts h o u l db en o t e dt h a tw eh a v ee m p l o y e dm o d e l s
where HIC was overexpressed or knocked-down in vivo,
or added in excess amounts when used with in vitro
nuclear import assays, and that HIC inhibitory effects
on Rev function or Rev nuclear import were dose
dependent. Collectively, these observations suggest that
HIC acts as a cellular competitor with importin b for
binding the Rev NLS, and that the balance between HIC
and importin b could influence the rate of Rev nuclear
import. Interestingly, we and others have recently
described that the expression of HIC is tightly regulated
at the transcriptional level [37,38]. Furthermore, com-
pared to 293T where endogenous levels of HIC expres-
sion are sufficient to down-modulate HIV-1 Rev activity,
HIC is highly expressed in PBMCs and more specifically
in HIV-1 target cells, including CD4+ T-cells and
monocytes [37]. Additionally, it is also possible that
post-transcriptional modification(s) could modulate the
relative affinity of Rev NLS for HIC and importin b, and
mediate Rev release from sites of sequestration in the
cytoplasm. In this regard, Rev is a target of the protein
kinase CK2, which phosphorylates Rev at Ser5, Ser8 and
results in the conformational change of a region encom-
passing the NLS domain [39,40]. In addition, Rev Lys33
is also a target of ubiquitination [41].
In the present study, we also attempted to characterise
Rev nuclear import pathways within different cellular
environments and employed the M9 M peptide, which
was specifically designed to inhibit the transportin path-
way. Remarkably, HIC and M9 M had opposite effects
on Rev nuclear import in a cell type-specific fashion. As
previously described by Hutten et al.,M 9Mi n h i b i t e d
Rev nuclear import in the presence of HeLa cytosolic
extracts [23]. Similarly, M9 M but not HIC, inhibited
Rev nuclear import using U937 and THP-1 cellular
extracts. These results further substantiate the view that
transportin and not importin b acts as the major import
receptor for Rev in HeLa, U937 and THP-1 cells.
Figure 8 HIC inhibits HIV-1 Rev function in Jurkat and CEM but
not in U937 or THP-1. Jurkat, CEM, U937 and THP-1 cells were
transfected with 1 μg of pDM128-RRE combined with 0.5 μg of HA-
Rev and 4 μg of FLAG HIC or parent plasmid. Relative CAT activity
was analysed 24 hours post-transfection as described before. Values
are mean ± standard deviation. Data are representative of a
minimum of three independent experiments performed in triplicate.
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extracts were employed, HIC but not M9 M inhibited
Rev nuclear import, revealing that importin b but not
transportin is the dominant nuclear import pathway in
these cells. Finally, using a CAT reporter gene assay,
overexpression of HIC was shown to reduce Rev activity
in 293T, Jurkat and CEM cells. These results were sub-
stantiated by siRNA knockdown of endogenous HIC,
which remarkably increased Rev activities in 293T cells.
In contrast, HIC had no significant effect on Rev func-
tion in HeLa, U937 and THP-1 cells. Collectively, these
findings support the hypothesis that Rev nuclear import
pathways is determined by the cellular context and that
importin b and transportin alternate as major import
receptors for Rev in a cell specific and mutually exclu-
sive fashion. Remarkably, we also revealed here that
while HIC displaces importin b from Rev NLS, Rev
could bind simultaneously to both HIC and transportin,
strongly suggesting that the molecular determinants for
Rev binding to importin b and transportin are different.
The multivalent nature of the Rev NLS for multiple
import factors would enable Rev to exploit multiple
import pathways and to adapt its nuclear trafficking
strategy to different cellular environments.
Given the observed effects of HIC on both Tat and Rev
localisation and functions, it would be of interest to cor-
relate their respective use of specific nuclear import path-
ways and the cell specific HIC endogenous level of
expression, with HIV-1 replication and to distinguish the
effects of HIC-Tat and HIC-Rev interactions on HIV-1
life cycle by employing Tat- or Rev-independent viruses.
Finally, we also describe how HIC interacts and inter-
feres with SV40T NLS nuclear import, which constitutes
the archetype of import mediated by the importin a/b
pathway. Interestingly, other reports describe interac-
tions of HIC and I-mfa with basic regions. These
include the Axin GSK-3 binding domain, and Cyclin T1
KRM, both of which have a high K/R residue content
[26,27]. It would be of interest to investigate if HIC
could also modulate their nuclear import.
Conclusions
We have identified HIC as a novel cellular cofactor for
the HIV-1 regulatory protein Rev. We propose that the
intermolecular masking of Rev NLS by HIC by which
HIC control of Rev nuclear import can contribute to the
spatial control of its activity. We also show that Rev
nuclear import is cell specific and alternatively mediated
by transportin or importin b.
Methods
DNA constructs and plasmids
pCAGGS-HA-Rev was created by cloning Rev (aa 1-116)
sequence into pCAGGS [42]. pFLAG-HIC, pFLAG-HIC
(2-144), pFLAG-HIC(144-246) and pDM128-RRE were
described previously [25,43]. pGEX-GST-SV40TNLS-
GFP, pGEX-GST-importin b, pQE80-RanQ69L, pGEX-
GST-YFP, GST-M9 M and His-tagged transportin and
importin b vectors were described previously [32,44-47].
pGEX-GST-YFP-M9: M9 sequence encoding hnRNP A1
(aa268-305) was cloned into pGEX-GST-YFP [48].
pGEX-GST-YFP-Rev (aa1-116), pGEX-GST-YFP-
RevΔN1 (aa35-116), pGEX-GST-YFP-RevΔN2 (aa46-
116) and pGEX-GST-YFP-RevNLS (aa35-46) were gen-
erated by cloning Rev relevant sequences into pGEX-
GST-YFP (Figure 7A). pBAD/6×His-HIC was described
previously [25].
Western-Blotting analysis
Western-Blotting analysis was performed using BioTra-
ce™PVDF (Pall Corporation) and the SNAP i.d. Protein
Detection System (Millipore) according to the manufac-
turer’s instructions. The following primary antibodies
were employed: ANTI-MDFIC AB2 and ANTI-FLAG
M2 (Sigma); anti_HA High Affinity 3F10 (Roche);
Transportin 1 (D45), NTF97/Importin beta (3E9) and
Tubulin antibodies (Abcam). The following secondary
antibodies (GE Healthcare) were employed: ECL™Anti-
mouse IgG and ECL™Anti-rabbit IgG.
Cell culture and Transfection
293T, HeLa and COS7 cell lines were maintained in
Dulbecco’s modified Eagle’sm e d i u m( D M E M )w i t h0 . 3
gm/L of L-Glutamine (GIBCO) supplemented with 10%
fetal calf serum and antibiotics. Jurkat, CEM, THP-1
and U937 cell lines were cultured in RPMI 1640 med-
ium containing 10% fetal calf serum and supplemented
with 0.3mg/L of L-Glutamine (GIBCO) and antibiotics.
Transient DNA transfections were performed using
FuGENE6 (Roche Diagnostics, Mannheim, Germany)
according to the manufacturer’sp r o t o c o l .T h et o t a l
amount of DNA was equilibrated by addition of parent
plasmid. Approximately 30,000 HeLa cells and 60,000
293T cells were reverse-transfected with siRNA (30
pmol) in individual wells of a 24 well plate using Lipo-
fectamine™ RNAiMAX (Invitrogen) according to manu-
facturer’s instructions. siRNAs were obtained from
QIAGEN: MDFIC_3 (5’-GGAUUGUAGGAGUGGAA
GATT-3’), MDFIC_5 (5’GGAGUGAGCUGGCUG
GAAATT-3’), MDFIC_7 (5’-CAUGAGAUUUAGCAGA
CUATT-3’) and luciferase GL2 siRNA (negative con-
trol). Quantitative real time RT-PCR analysis of HIC
mRNA expression was performed 72 hours post-trans-
fection as described before (Gu et al., 2009).
Nucleofection
Jurkat, CEM, U937 and THP-1 cells were transfected by
nucleofection with the Nucleofector device I from
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Nucleofector Kit C, according the manufacturor’s
instructions. Total amount of DNA was equilibrated by
addition of parent plasmid.
Purification of Recombinant Proteins
Recombinant GST fusion proteins (GST-YFP Rev/
RevΔN1/RevΔN2/RevNLS/M9, GST-SV40TNLS-GFP,
GST- importin b,G S T - M 9 M )a n dH i s - t a g g e dp r o t e i n s
(RanQ69L, importin b, transportin, HIC) were produced
as described previously [25,32,44-47].
Co-immunoprecipitation Studies
293T cells were transfected with 4 μg of pCAGGS-HA-
Rev and/or 1 μg of pFLAG-HIC. 48 hours post-transfec-
tion, cells were lysed in 200 μl Native lysis buffer (TBS
with 5 mM EDTA PH 8.0, 10 mM NaF, 1% Triton X-
100, 10 mM DTT, protein inhibitors). Lysates were
incubated with 20 μl of HA Matrix affinity (Roche) at 4°
C, overnight and bound complexes were eluted in
Leammli sample buffer. Western-Blotting was carried
out using Anti-HA High Affinity 3F10 (Roche) or Anti-
FLAG M2 monoclonal antibody (Sigma).
Co-localisation Studies
COS7 cells were transfected with 0.5 μg of pCAGGS-
HA Rev, and/or 0.5 μg of pFLAG HIC, pFLAG-HIC(2-
144), and/or pFLAG-HIC(144-246). 48 hours post-trans-
fection, cells were fixed in 4% paraformaldehyde and
permeabilised with 0.2% Triton X-100. Indirect immnu-
nofluorescence was performed using Anti-HA High Affi-
nity 3F10 (Roche), Anti-FLAG M2 monoclonal antibody
(Sigma) as primary antibodies, and anti-rat Ig-Biotin
(DAKO), anti-rabbit Ig (Molecular Probes), Streptavidin
Texas Red 594 (Molecular Probes) and anti Mouse IgG1
FITC (Molecular Probes) as secondary antibodies.
Stained cells were visualized using an Olympus BX50
fluorescent microscope and DP70 camera.
In vitro nuclear import assay
293T, HeLa, COS7, THP-1, U937, CEM and Jurkat cyto-
solic extractions were performed as described previously
[49]. In vitro nuclear import assays and control experi-
ments were performed with HeLa cells as described pre-
viously [44]. Competitive In vitro nuclear import assays
were performed by using GST-YFP-Rev/Rev NLS/
RevΔN1/RevΔN2, GST-YFP-M9, GST-SV40TNLS-GFP
as nuclear import substrate. RRL, 293T, HeLa, COS7,
U937, Jurkat, CEM and THP-1 cytosolic extracts,
recombinant N-His importin b or transportin C-His
were employed as source of nuclear import factors. The
addition of competitive and increasing amount of
recombinant 6ΧHis HIC (0.5 to 4 μg) or GST-M9 M (4
μg), were employed for the competition assay. Images
were captured using using an Olympus BX50 fluores-
cent microscope and DP70 camera. Cytosolic extracts
(10 μg) were also subjected to Western Blot analysis to
monitor the endogenous expression levels of importin b
and transportin.
In vitro “pull down” assay
GST pull down assays were performed as previously
described [25]. Competitive in vitro GST pull down
experiments were performed by adding 4 μg of recombi-
nant N-His importin b or transportin C-His and
increasing amount (0.5 to 4 μg) of recombinant 6ΧHis
HIC to 0.5 μg of GST-YFP-Rev/Rev NLS immobilized
on glutathione sepharose (Amersham).
Chloramphenicol acetyltransferase (CAT)-ELISA assay
293T and HeLa cells were transfected with 0.1 μgo f
CAT reporter gene DM128-RRE combined with
pCAGGS-HA-Rev (0.05 μg), pFLAG-HIC (1-4 μg) or
parent plasmid. Jurkat, CEM, U937 and THP-1 cells
were transfected with 1 μg of CAT reporter gene
DM128-RRE combined with pCAGGS-HA-Rev (0.5 μg),
pFLAG-HIC (4 μg) or parent plasmid. For all cell lines,
pRL-TK (Promega) was also transfected to control for
transfection efficiency. 24 h post-transfection, the CAT-
ELISA assays (Roche) were performed according to the
manufacturer’s protocols. Alternatively, 24 hours follow-
ing reverse-transfection of HIC siRNAs (30pmoles) or
control Luciferase GL2 (30pmoles) siRNA, cells were
transfected with DM128-RRE (0.2 μg), pRL-TK (0.02 μg)
and pCAGGS-HA-Rev (0.02 μg) or its parent plasmid
and CAT assay was performed 48 hours post-transfec-
tion. Cell lysates were also subjected to Western Blot
analysis to monitor HIC and Rev expression levels.
Additional material
Additional file 1: Supplementary Figure 1: HIV-1 Rev dominant
nuclear import pathways are cell specific. Nuclear import of GST-
YFP-Rev, GST-YFP-M9 and GST-SV40T NLS-GFP were examined
using in vitro nuclear import assays. Digitonin permeabilized HeLa
cells were incubated with 10 μl of reaction mixtures containing 1 μgo f
an import substrate, ATP regeneration system, and THP-1/CEM/COS7
cytosolic extracts. Recombinant 6×His-HIC at 0.5, 1 or 2 μg was added.
Rev nuclear signal intensities were analyzed by ImageJ for a minimum of
100 cells and illustrated by box plots. Statistical significance analysis was
performed with a two-tailed unpaired Student’s t test *, P < 0.05; **, P <
0.01; ***, P < 0.001
Additional file 2: Supplementary Figure 2: Endogenous expression
levels of importin-b, transportin and HIC in HeLa, 293T, COS7,
Jurkat, CEM, THP-1, U937 cytosolic extracts. The seven different
cytosolic extracts (10 μg) employed for the in vitro nuclear import assay
were tested by WB for Importin-b, transportin and HIC endogenous
expression levels.
Additional file 3: Supplementary Figure 3: Rev expression remains
unaffected following the modulation of HIC expression. A. Rev
expression remains constant following HIC over-expression.
Corresponding lysates of 293T or Hela cells transfected with 0.1 μgo f
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were analysed by Western-Blot (WB) for HIC and Rev expression. a-
Tubulin was employed as a loading control. B. siRNA-mediated
knockdown of HIC has no effect on Rev expression. Corresponding
lysates of HeLa and 293T cells, reverse-transfected with three distinct HIC
siRNAs or negative control, and subsequently transfected with DM128-
RRE, pRL-TK and pCAGGS-HA-Rev or its parent plasmid were analysed by
WB to monitor the expression levels of HA-Rev and endogenous HIC. a-
Tubulin was employed as a loading control.
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